An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Intensity Therapeutics is ...

Intensity Therapeutics (INTS) has delivered a -41.590% change over the past year, with a 52-week range between 0.407 and 43.500. What Is the Average Daily Trading Volume of Intensity Therapeutics ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Intensity Therapeutics, Inc. is a clinical-stage biotechnology company, which develops novel immune-based therapeutic products for cancer treatment. Its product, INT230-6, is a formulation consisting ...